These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9751448)

  • 1. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
    Wu G; Furlanut M
    J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
    Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
    J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin monitoring: one or two serum levels?
    Andrés I; López R; Pou L; Piñol F; Pascual C
    Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
    Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
    Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictions of serum vancomycin concentrations by means of six different equations for calculation of creatinine clearance.
    Wu G; Furlanut M
    Int J Clin Pharmacol Res; 1997; 17(1):1-10. PubMed ID: 9403347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
    Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
    Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pharmacokinetic model on vancomycin peak concentration targets.
    Fernandez de Gatta MM; Fruns I; Calvo MV; Lanao JM; Dominguez-Gil A
    Ther Drug Monit; 1996 Apr; 18(2):145-8. PubMed ID: 8721276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
    Pryka RD; Rodvold KA; Garrison M; Rotschafer JC
    Ther Drug Monit; 1989; 11(4):450-4. PubMed ID: 2741194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.
    Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W
    J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
    Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
    Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Bayesian method for predicting vancomycin dosing.
    Burton ME; Gentle DL; Vasko MR
    DICP; 1989 Apr; 23(4):294-300. PubMed ID: 2728513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and non-linear least squares methods.
    Wu G; Cossettini P; Furlanut M
    Pharmacol Res; 1996; 34(1-2):47-57. PubMed ID: 8981556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of predictability for vancomycin dosage regimens by the Bayesian method with Japanese population pharmacokinetic parameters.
    Teramachi H; Hatakeyama H; Matsushita R; Imai Y; Miyamoto K; Tsuji A
    Biol Pharm Bull; 2002 Oct; 25(10):1333-8. PubMed ID: 12392090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
    Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
    J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations.
    Chung JY; Jin SJ; Yoon JH; Song YG
    J Korean Med Sci; 2013 Jan; 28(1):48-54. PubMed ID: 23341711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.